Search

everythinglearnresearchcommunity

for

Search:↓

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

The hairless (hr) gene is essential for normal hair follicle function and its mutation leads to hair loss.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Thyroid hormones affect hair follicle stem cells by promoting differentiation and reducing growth.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Skin and hair can help us understand organ regeneration, especially how certain stem cells might be used to form new organs.

New model shows muscle affects hair loss differently in men and women.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Traction may not be the only cause of cicatricial marginal alopecia.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Researchers developed a method to grow hair follicle cells for transplantation using a special chip.

Skin stem cells are maintained by signals from nearby cells and vary in their ability to renew and mature.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Liposomes and iontophoresis effectively deliver protective enzymes into the skin against UV damage.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Plucked hair follicles can help diagnose scalp lupus.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.